Stage IV Melanoma
Oncology
4
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
3
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
150%
Monoclonal Antibody
150%
+ 2 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Abbottvolociximab
AngimmuneA-dmDT390-bisFv
EisaiLenvatinib
Kyowa Hakko KirinKW-2871
Clinical Trials (4)
Total enrollment: 121 patients across 4 trials
A Study of Volociximab in Metastatic Melanoma
Start: Dec 2006Est. completion: Mar 200819 patients
Phase 2Terminated
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Start: Jan 2017Est. completion: Jun 2018
Phase 1/2Unknown
E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma
Start: Apr 2010Est. completion: Nov 201497 patients
Phase 1/2Completed
A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma
Start: Nov 20045 patients
Phase 1/2Terminated
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
2h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
2h ago
Office Administrator
SystImmune
2h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
3h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
3h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
3h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space